Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$150.14
▼ $2.96 (−1.93%) today
Markets open · 3:53pm ET

MRK Coverage

Page 72
2:59pm ET
Investing

The 52-Week Low Club (SGP)(MRK)(MO)

Schering-Plough (SGP) Bad news on key cholesterol drug marketed with Merck. Shares fall to $14 from 52-week high of $33.81. Merck (MRK) Pulled down for the same reason. Sells off to $36.82…

Douglas A. McIntyre
7:45am ET
Health and Healthcare

Merck & Schering-Plough Face Cholesterol Firing Squad (MRK, SGP)

Usually drug companies look forward to presenting data on their drugs and medical treatments.  The the American College of Cardiology meeting was this weekend, and the findings and recommendations are worse than…

MRK
Douglas A. McIntyre
7:44am ET
Health and Healthcare

Merck’s Guidance A Relief (MRK)

Merck & Co. (NYSE: MRK) has just posted earnings that may be a relief to many who were worried about recent Vytorin woes affecting 2008 numbers.  The company posted EPS of $0.80…

MRK
Douglas A. McIntyre
2:59pm ET
Investing

More DJIA Earnings Pressing (MO, MRK, PG, XOM)

We are over half-way through earnings season now, but we still have four DJIA components set to report earnings this week.  We’ve also provided a link here to see which targets are…

Douglas A. McIntyre